GL1X · GenesisL1 explorer

MolNFT v1 · #136789 · protein

Crystal structure of mtb PKS13 thioesterase domain in complex with inhibitor TAM16

5V3Y · Polyketide synthase PKS13 (termination polyketide synthase): “Crystal structure of mtb PKS13 thioesterase domain in complex with inhibitor TAM16”. X-ray diffraction, 2 ligands (5V8, SO4), 8 pockets (best druggability 0.74). MolNFT…

PDB
5V3Y
Type
protein
Length
542 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Polyketide synthase PKS13 (termination polyketide synthase)
EC
2.7.7.-
UniProt
A0A0T9CRX1
Ligands
5V8, SO4
Pockets
8 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APolyketide synthase PKS13 (termination polyketide synthase) (EC 2.7.7.-)protein26947% helix, 15% strandA0A0T9CRX1
BPolyketide synthase PKS13 (termination polyketide synthase) (EC 2.7.7.-)protein27346% helix, 15% strandA0A0T9CRX1

Ligands and binding sites

  • 5V8 · 2-(4-hydroxyphenyl)-~{N}-methyl-5-oxidanyl-4-(piperidin-1-ylmethyl)-1-benzofuran-3-carboxamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15280.740.82555V8
25370.660.77555V8
33090.530.7528empty
4760.440.8117empty
51330.440.7728empty

Interfaces

1 interface between chains.

  • A–B · 593 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 5V3Y · Crystal Structure of Mtb Pks13 Thioesterase domain in complex with inhibitor TAM16 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.